Table 1.

Nuclear β-catenin expression in CSCC according to the patients’ clinicopathologic characteristics

Characteristic	No. of Patients	Nuclear	β-catenin	P value
		Positive	Negative
Age (y)
≤ 50	132	25	107
> 50	39	4	35	.072
FIGO Stage
I	107	24	83
II	64	5	59	.019
Differentiation
Well	3	1	2
Moderate	65	11	54
Poor	103	17	86	.746
Tumor Size
≤ 4 cm	125	24	101
> 4 cm	46	5	41	.254
Nodal Metastasis
+	27	6	21
-	144	23	121	.411
Total No. of Patients	171	29	142